💬 A Message to Patients: Why This New Information Can Be Reassuring — Not Frightening
We understand that learning about things like biofilms, the lung microbiome, or how different bugs work together might feel a little overwhelming or even alarming. These topics are complex and unfamiliar to many.
But we want you to know: this science is already improving care for people with aspergillosis — and you don’t need to understand every detail for it to help you.
✅ Examples of How Biofilm Awareness Is Already Helping Patients
🧪 1. Combined Treatment for Coinfection
People who have both Aspergillus and Pseudomonas infections are now more likely to be:
-
Tested for both microbes
-
Given combination therapy (e.g. antifungals + inhaled antibiotics)
This reduces the risk of persistent symptoms and lowers the chance of hospital admission.
🌬 2. Inhaled Therapies That Reach Biofilms
Doctors are now using or trialling inhaled medications that can:
-
Reach fungal and bacterial biofilms more directly
-
Work even when oral drugs can’t penetrate
For example, inhaled colistin or tobramycin is used in bronchiectasis; inhaled antifungals (like opelconazole) are in trials for aspergillosis.
💡 3. Chest Physiotherapy and Mucus Clearance
Biofilm research has shown that many infections hide in thick mucus. So, clearing mucus isn’t just for comfort — it’s a critical part of treatment.
-
More patients now receive airway clearance devices
-
Some are referred for specialist physiotherapy to support this
🧼 4. Better Infection Control in Hospital
Because we understand that biofilms form on equipment and even in hospital air systems, specialist centres like NAC use:
-
HEPA-filtered rooms
-
Strict protocols to prevent airborne contamination
This lowers the risk of acquiring new fungal infections during hospital stays.
📊 5. More Personalised Care
Some patients now receive tailored treatment plans based on:
-
Sputum cultures that show which organisms are present
-
Whether biofilm-forming species are involved
-
Coexisting inflammation, allergies, or colonisation patterns
This is a big shift from one-size-fits-all prescriptions.
💬 Final Reassurance
These discoveries don’t mean there’s something worse going on. They mean that:
Doctors now understand more
Treatments are becoming more precise
We can often treat fewer times, more effectively
You’re not alone — and you’re not expected to keep up with every detail. This information helps your care team make better choices for you, reduce flare-ups, and improve quality of life. And that’s what really matters.
Share this post
Latest News posts
COVID Vaccination Side Effects
April 26, 2021
How to manage breathlessness
April 23, 2021
Indoor Air Quality at Home (NHS guidelines )
April 12, 2021
Aspergillosis monthly patient & carer meeting
April 7, 2021
COVID Vaccination – hesitating?
February 24, 2021
What is an MDT?
February 17, 2021
Aspergillosis Monthly Patient & Carer Meeting
February 5, 2021
World Aspergillosis Day 2021
February 2, 2021
World Aspergillosis Day, 1 February 2021
January 28, 2021
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
